Some suggested, although nonspecific, risk factors for this condition are old age, postmenopausal state, increased tumor size and invasion, elevated levels of some tumor markers (CA125, CA19-9, and CEA), and tumor remnants [5, 6], but the only way to confirm malignant transformation is through histopathologic study. This evidence concerns the gene MUC16 and neoplasm.